Sucralfate
Sucralfate is an ulcer-protecting medicine used to treat active duodenal ulcers (ulcers in the first part of the small intestine), and tablet forms are also used to help keep them from coming back.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 74 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Sucralfate (Carafate) treats active duodenal ulcers, ulcers in the first part of the small intestine, by sticking to the ulcer and coating it against stomach acid and digestive juices while it heals; an older standby on the market since about 1981 and available generically, it is now usually a second choice behind acid-reducing medicines. Very little is absorbed, so it is generally well tolerated, and constipation is the side effect people notice most. The main thing to watch is timing, since it can block other medicines from being absorbed, so take it on an empty stomach and space antacids and other drugs away from it.
Clinical pearls
- Take medicines like levothyroxine, digoxin or fluoroquinolone antibiotics 2 hours before sucralfate so its coating cannot block their absorption.
- Keep antacids 30 minutes away on either side, and favor ones without aluminum, which adds to your total intake.
- If you have chronic kidney failure or are on dialysis, tell your prescriber, since the aluminum in sucralfate can build up.
- Finish the full 4 to 8 weeks even if pain eases sooner, unless your doctor confirms the ulcer has healed.
Patient information guide A plain-language walkthrough of Sucralfate, written from its FDA label.
What Sucralfate is used for
▾
Sucralfate is used to treat and prevent the return of duodenal ulcers.
- Short-term treatment (up to 8 weeks) of active duodenal ulcer: Carafate tablets, sucralfate tablets, Carafate oral suspension and sucralfate oral suspension.
- Maintenance therapy at a reduced dose after an ulcer has healed: Carafate tablets and sucralfate tablets, USP.
How Sucralfate works
▾
Sucralfate works locally at the ulcer site. It forms a sticky coating over the ulcer that acts as a barrier against acid, pepsin and bile salts. This protects the ulcer so it can heal.
Only a very small amount is absorbed into the body.
Sucralfate dosage
▾
Sucralfate comes as tablets and as an oral suspension, and is taken by mouth.
- Active ulcer: the label describes four doses a day on an empty stomach.
- Healing may begin in 1 to 2 weeks, but treatment usually continues 4 to 8 weeks unless healing has been confirmed by x-ray or endoscopy (a camera exam).
- Tablet maintenance therapy: taken at a lower, less frequent schedule, about twice a day.
- Antacids can be used for pain, but not within 30 minutes before or after sucralfate.
Follow your prescriber's and label directions.
Dosing details from the FDA-approved label
From the Sucralfate prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Active Duodenal Ulcer
- 1 g four times per day on an empty stomach (oral suspension: 1 gram (10 mL) four times per day)
- Treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination
- Antacids may be given as needed for pain but not within one-half hour before or after sucralfate
- Maintenance Therapy
- 1 g twice a day
- Elderly
- Dose selection should be cautious, usually starting at the low end of the dosing range
- Reflects greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION Active Duodenal Ulcer The recommended adult oral dosage for duodenal ulcer is 1 g four times per day on an empty stomach. Antacids may be prescribed as needed for relief of pain but should not be taken within one-half hour before or after sucralfate. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance Therapy The recommended adult oral dosage is 1 g twice a day. Elderly In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy (see PRECAUTIONS , Geriatric Use ). Call your doctor for medical advice about side effects. You may report side effects to TEVA USA, PHARMACOVIGILANCE at 1-866-832-8537 or [email protected]; or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Read the full Dosage and Administration section on DailyMed →
Sucralfate side effects
▾
Side effects are usually minor and rarely led people to stop the medicine in studies.
Common side effects
- Constipation (the most common)
- Diarrhea
- Nausea or vomiting
- Upset stomach, indigestion or gas
- Dry mouth
- Dizziness, sleepiness or trouble sleeping
- Itching or rash
- Headache or back pain
- Dizziness, sleepiness, trouble sleeping, vertigo
When to get medical help
- Get urgent help for signs of a serious allergic reaction: trouble breathing, swelling of the lips, face, mouth or throat, hives, or a rash with itching.
- Call your doctor if you have ongoing stomach pain, vomiting or a feeling of blockage. Bezoars (hard masses of material in the stomach) have been reported with sucralfate.
- Sucralfate must never be injected into a vein. Accidental injection has caused fatal complications, including blood clots in the lungs and brain.
Sucralfate warnings and precautions
▾
- Never inject it. Sucralfate is not for intravenous use. Accidental injection has caused fatal complications, including emboli (blood clots) in the lungs and brain.
- Serious allergic reactions have been reported, including trouble breathing, hives and swelling.
- Bezoars (hard masses in the stomach) have been reported, mostly in people with conditions like delayed stomach emptying or on tube feedings.
- Aluminum can build up in people with chronic kidney failure or on dialysis. Use with caution.
Sucralfate interactions
▾
Sucralfate can bind to other medicines in the gut and reduce how much you absorb.
- Cimetidine, ranitidine, digoxin, fluoroquinolone antibiotics, ketoconazole, levothyroxine, phenytoin, quinidine, tetracycline and theophylline: absorption may drop.
- Warfarin: low clotting test results were reported in some cases, though studies showed no change.
- Antacids: keep 30 minutes apart.
- Aluminum-containing products: may add to aluminum buildup.
- Taking the other medicine 2 hours before sucralfate eliminated the interaction in studied cases.
Interactions listed in the FDA-approved label
From the Sucralfate prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Cimetidine: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of cimetidine. Dosing the concomitant medication 2 hours before sucralfate eliminated the interaction.
- Digoxin: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of digoxin. Dosing the concomitant medication 2 hours before sucralfate eliminated the interaction.
- Fluoroquinolone antibiotics: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of fluoroquinolone antibiotics. Dosing the concomitant medication (ciprofloxacin, norfloxacin, ofloxacin) 2 hours before sucralfate eliminated the interaction.
- Ketoconazole: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of ketoconazole. Administer CARAFATE separately from other drugs when alterations in bioavailability are felt to be critical; monitor patients appropriately.
- L-thyroxine: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of l-thyroxine. Administer CARAFATE separately from other drugs when alterations in bioavailability are felt to be critical; monitor patients appropriately.
- Phenytoin: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of phenytoin. Administer CARAFATE separately from other drugs when alterations in bioavailability are felt to be critical; monitor patients appropriately.
- Quinidine: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of quinidine. Administer CARAFATE separately from other drugs when alterations in bioavailability are felt to be critical; monitor patients appropriately.
- Ranitidine: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of ranitidine. Dosing the concomitant medication 2 hours before sucralfate eliminated the interaction.
- Tetracycline: Simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of tetracycline. Administer CARAFATE separately from other drugs when alterations in bioavailability are felt to be critical; monitor patients appropriately.
- Warfarin: Subtherapeutic prothrombin times with concomitant warfarin and sucralfate have been reported in case reports, but two clinical studies showed no change in serum warfarin concentration or prothrombin time. Administer CARAFATE separately from other drugs when alterations in bioavailability are felt to be critical; monitor patients appropriately.
Read the label’s full interactions text
Drug In t e r a c t io n s Some studies have shown that simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of the following: cimetidine, digoxin, fluoroquinolone antibiotics, ketoconazole, l-thyroxine, phenytoin, quinidine, ranitidine, tetracycline, and theophylline. Subtherapeutic prothrombin times with concomitant warfarin and sucralfate therapy have been reported in spontaneous and published case reports. However, two clinical studies have demonstrated no change in either serum warfarin concentration or prothrombin time with the addition of sucralfate to chronic warfarin therapy. The mechanism of these interactions appears to be nonsystemic in nature, presumably resulting from sucralfate binding to the concomitant agent in the gastrointestinal tract. In all case studies to date (cimetidine, ciprofloxacin, digoxin, norfloxacin, ofloxacin, and ranitidine), dosing the concomitant medication 2 hours before sucralfate eliminated the interaction. Because of the potential of CARAFATE to alter the absorption of some drugs, CARAFATE should be administered separately from other drugs when alterations in bioavailability are felt to be critical. In these cases, patients should be monitored appropriately.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Sucralfate
▾
- Do not use if you are allergic to sucralfate or any of its ingredients.
- Tell your doctor if you have chronic kidney failure or are on dialysis.
- Older adults usually start at the low end of the dosing range.
- Mention delayed stomach emptying or tube feedings.
- Share a full list of your medicines and supplements.
Sucralfate overdose
▾
Overdose experience in humans is limited, so no specific treatment is recommended. Because so little sucralfate is absorbed, risks are expected to be minimal. In rare reports, most people had no symptoms, and some had indigestion, stomach pain, nausea or vomiting.
What Sucralfate does in the body
▾
Sucralfate forms an ulcer-adherent complex that covers the ulcer. In people, doses used for ulcer therapy reduced pepsin activity in stomach juice by 32%. It also binds bile salts and has some acid-neutralizing capacity.
How your body processes Sucralfate
▾
Sucralfate is only minimally absorbed from the digestive tract. The small amount absorbed is passed out mainly in the urine. Its effect comes from action at the ulcer site, not from levels in the blood.
How to store Sucralfate
▾
Store at Controlled room temperature 59-86°F (15-30°C).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Sucralfate
17 supplements and herbal products have documented interactions with Sucralfate in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 7
- Minor · 9
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Sucralfate has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Sucralfate: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Sucralfate — the kind of thing our pharmacy team would talk through with you at the counter.
What is sucralfate for?
▾
How should I take it?
▾
Can I take antacids with it?
▾
What side effects should I expect?
▾
When should I get help right away?
▾
Does it affect my other medicines?
▾
Is Sucralfate available over the counter?
▾
When was Sucralfate first available?
▾
Who makes Sucralfate?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Sucralfate on HelloPharmacist
Sucralfate forms and strengths (how it comes)
Sucralfate is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Sucralfate inactive ingredients by manufacturer.
Tablet
How this form is used
- Carafate tablets are used for short-term (up to 8 weeks) treatment of active duodenal ulcer.
- Carafate tablets are also used as lower-dose maintenance therapy after an ulcer has healed.
- Sucralfate tablets, USP are used for short-term treatment of active duodenal ulcer and for maintenance therapy after healing.
- Carafate tablets are taken on an empty stomach, four times a day, for active ulcer treatment.
- Sucralfate tablets are taken on an empty stomach for active ulcer treatment, usually for 4 to 8 weeks.
- Carafate and sucralfate tablets: maintenance therapy is taken less often, about twice a day.
- Carafate and sucralfate tablets: avoid antacids within 30 minutes before or after a dose.
Oral suspension
How this form is used
- Carafate oral suspension is used for short-term (up to 8 weeks) treatment of active duodenal ulcer.
- Sucralfate oral suspension is used for short-term (up to 8 weeks) treatment of active duodenal ulcer.
- Carafate oral suspension is taken by mouth four times a day on an empty stomach.
- Sucralfate oral suspension is taken by mouth on an empty stomach, four times a day.
- Carafate and sucralfate oral suspension: avoid antacids within 30 minutes before or after a dose.
Topical cream, ointment or gel
Sucralfate on the U.S. market: products, makers and brands
How Sucralfate appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
43 companies list 71 Sucralfate product records with the FDA, mostly as tablet, oral suspension, topical cream, ointment or gel; the earliest marketing or approval year on record is 1981. Brand names on the directory include Carafate; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (22) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Sucralfate is used (Medicaid data)
A general measure of how commonly Sucralfate is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Sucralfate is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Sucralfate prescribed? Of the 1,601 medications we measure, Sucralfate ranks #215 by Medicaid prescriptions — more than 87% of them.
Utilization by Sucralfate product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
sucralfate 1000 MG Oral Tablet Most dispensed
Summed across the 13 of 128 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 314234
sucralfate 100 MG/ML Oral Suspension
Summed across the 17 of 75 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 313123
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Sucralfate, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 30 of 203 listed Sucralfate NDCs with Medicaid activity.
Compare Sucralfate products
A representative set of FDA-listed product records for Sucralfate — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Oral suspension | ||||
| 1 g/10 mL | Oral | Allergan, Inc. | NDA | View NDC → |
| 1 g/10 mL | Oral | American Health Packaging | ANDA | View NDC → |
| 1 g/10 mL | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 1 g/10 mL | Oral | Atlantic Biologicals Corp. | ANDA | View NDC → |
| 1 g/10 mL | Oral | AvKARE | ANDA | View NDC → |
| 1 g/10 mL | Oral | AvPAK | ANDA | View NDC → |
| 1 g/10 mL | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 1 g/10 mL | Oral | Cardinal Health 107, LLC × 2 listings | ANDA | View NDC → |
| 1 g/10 mL | Oral | Chartwell Governmental & Specialty RX, LLC | ANDA | View NDC → |
| 1 g/10 mL | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 1 g/10 mL | Oral | Cosette Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 g/10 mL | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 1 g/10 mL | Oral | Kesin Pharma Corporation | ANDA | View NDC → |
| 1 g/10 mL | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 1 g/10 mL | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 g/10 mL | Oral | Pacific Pharma, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 1 g/10 mL | Oral | PAI Holdings, LLC dba PAI Pharma | ANDA | View NDC → |
| 1 g/10 mL | Oral | Precision Dose, Inc. | ANDA | View NDC → |
| 1 g/10 mL | Oral | Richmond Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 g/10 mL | Oral | Safecor Health, LLC | ANDA | View NDC → |
| 1 g/10 mL | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 1 g/10 mL | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
| 1 g/10 mL | Oral | TruPharma, LLC | ANDA | View NDC → |
| 1 g/10 mL | Oral | VistaPharm, LLC | ANDA | View NDC → |
| 💊Tablet | ||||
| 1 g | Oral | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| 1 g | Oral | A-S Medication Solutions | ANDA | View NDC → |
| 1 g | Oral | Advanced Rx of Tennessee, LLC | ANDA | View NDC → |
| 1 g | Oral | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | View NDC → |
| 1 g | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 1 g | Oral | Allergan, Inc. | NDA | View NDC → |
| 1 g | Oral | Amneal Pharmaceuticals NY LLC × 2 listings | ANDA | View NDC → |
| 1 g | Oral | Aphena Pharma Solutions - Tennessee, LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 1 g | Oral | Aphena Pharma Solutions - Tennessee, LLC | ANDA | View NDC → |
| 1 g | Oral | Asclemed Usa Inc. | ANDA | View NDC → |
| 1 g | Oral | AvKARE | ANDA | View NDC → |
| 1 g | Oral | Bryant Ranch Prepack × 6 listings | ANDA | View NDC → |
| 1 g | Oral | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | View NDC → |
| 1 g | Oral | Cardinal Health 107, LLC × 2 listings | ANDA | View NDC → |
| 1 g | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 1 g | Oral | Coupler LLC | ANDA | View NDC → |
| 1 g | Oral | Direct Rx | ANDA | View NDC → |
| 1 g | Oral | Direct_Rx | ANDA | View NDC → |
| 1 g | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 1 g | Oral | Mylan Institutional Inc. | ANDA | View NDC → |
| 1 g | Oral | Mylan Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 1 g | Oral | NCS HealthCare of KY, LLC dba Vangard Labs × 2 listings | ANDA | View NDC → |
| 1 g | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 1 g | Oral | Northwind Health Company, LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 1 g | Oral | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 g | Oral | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 1 g | Oral | Preferred Pharmaceuticals Inc | ANDA | View NDC → |
| 1 g | Oral | Preferred Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 1 g | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 g | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 1 g | Oral | Redpharm Drug | ANDA | View NDC → |
| 1 g | Oral | Safecor Health LLC | ANDA | View NDC → |
| 1 g | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 1 g | Oral | Viona Pharmaceuticals Inc | ANDA | View NDC → |
| 1 g | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
Showing 71 of 71 products — FDA National Drug Code Directory. See every product, package size and price: browse all 71 Sucralfate NDCs →
Sucralfate side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Sucralfate — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Sucralfate in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Sucralfate FDA approval history
How Sucralfate went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Sucralfate recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 2 Sucralfate recalls since July 2021. None of them is still listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16 Lots: Lot#: 810300, Exp 10/2023 FDA record D-0047-2024 →
- Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16 Lots: Lot #: 921100; Exp. 02/2025 FDA record D-1149-2023 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 10156 3 dose forms · 4 strengths
-
Dose form (SCDF) Oral Paste RxCUI 1487217In current FDA listingsClinical drug / strength (SCD) malate 100 MG/MLRxCUI 1487218 -
Dose form (SCDF) Oral Suspension RxCUI 373966In current FDA listings -
Dose form (SCDF) Oral Tablet RxCUI 373967In current FDA listingsClinical drug / strength (SCD) 1000 MGRxCUI 314234
Look up RxCUI 10156 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Sucralfate supply and shortage status
Whether Sucralfate is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Sucralfate costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet · Oral | 1 g | $0.173 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Sucralfate brand names
Sucralfate is sold under one brand name in the FDA directory — Carafate. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Sucralfate: manufacturers and labelers
43 companies list Sucralfate products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Cardinal Health 107, LLC, Advanced Rx Pharmacy of Tennessee, LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 19 more on the FDA NDC directory.
Sucralfate drug class (RxNorm)
Sucralfate belongs to the Aluminum Complex class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Sucralfate page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Allergan, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →